Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Sanofi Winthrop Industrie Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed…
#France #FR #Europe #EU #Sanofi #acceleratedapproval #betacell #bloodsugarlevels #children #clinicalbenefit #clinicalstudy #insulinproduction #Tzield
https://www.europesays.com/france/35068/